Lung cancer diagnosis can affect the whole family
Publication date: Available online 25 February 2020Source: The Lancet Respiratory MedicineAuthor(s): Tony Kirby
Conclusions L-SURmax showed the most powerful predictive performance than the other PET parameters in predicting occult lymph node metastasis. The combination of three independent risk factors (carcinoembryonic antigen, cytokeratin 19 fragment, and L-SURmax) can effectively predict occult lymph node metastasis in clinical N0 non–small cell lung cancer patients.
Publication date: Available online 6 April 2020Source: Journal of the American Society of CytopathologyAuthor(s): Rachel Jug, Coral X. Giovacchini, Beiyu Liu, Cindy Green, Jeffrey M. Clarke, Kamran Mahmood, Elizabeth N. Pavlisko
Lung cancer is more common in never smokers who have chronic obstructive pulmonary disease (COPD) than in ever smokers without COPD, concludes an observational study.Medscape Medical News
Lung cancer experts issued thoughtful recommendations on how to approach lung cancer during the pandemic while still limiting exposure to COVID-19 as patients are in hospital receiving treatment.Medscape Medical News
Publication date: Available online 6 April 2020Source: Journal of Molecular StructureAuthor(s): Saravanan Kandasamy, Prabhu Subramani, Selvi Subramani, John marshal Jayaraj, Gunasekaran Prasanth, Kannupal Srinivasan, Karthikeyan Muthusamy, Venkatachalam Rajakannan, Ravikumar Vilwanathan
No abstract available
npj Primary Care Respiratory Medicine, Published online: 07 April 2020; doi:10.1038/s41533-020-0173-3Predictive values of lung cancer alarm symptoms in the general population: a nationwide cohort study
Cancers, Vol. 12, Pages 896: Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET Cancers doi: 10.3390/cancers12040896 Authors: Tamminga Andree Hiltermann Jayat Schuuring van den Bos Spierings Lansdorp Timens Terstappen Groen Circulating tumor cells (CTCs) detected by CellSearch are prognostic in non-small-cell lung cancer (NSCLC), but rarely found. CTCs can be extracted from the blood together with mononuclear cell populations by diagnostic leukapheresis (DLA), therefore concentrating th...
AbstractLymph node assessment is an essential component of the treatment of lung cancer. Identification of the correct “N” stage is important for staging which in turn determines treatment. Assessment of lymph nodes may be accomplished using imaging with CT scan and PET–CT, invasive techniques such as mediastinoscopy, endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) or endoscopic ultrasoun d fine needle aspiration (EUS-FNA). Ultimately, regardless of any pre-resection assessment, lymph nodes must be assessed at the time of resection. The question to be addressed in this report is the ...
ConclusionsTheRASSF1A andSHOX2 genes are critical for the processes of tumorigenesis, development, metastasis, drug resistance, and recurrence in lung cancer. The combined detection ofRASSF1A andSHOX2 gene methylation was identified as an excellent method for the screening and surveillance of lung cancer that exhibits high sensitivity and specificity.